Literature DB >> 31264139

Circulating lipids, mammographic density, and risk of breast cancer in the Nurses' Health Study and Nurses' Health Study II.

Sarah A Lucht1, A Heather Eliassen2,3, Kimberly A Bertrand4, Thomas P Ahern5, Signe Borgquist6, Bernard Rosner2, Susan E Hankinson2,7, Rulla M Tamimi2,3.   

Abstract

PURPOSE: Epidemiologic evidence supports an association between high mammographic density and increased breast cancer risk yet etiologic mechanisms remain largely unknown. Mixed evidence exists as to whether circulating lipid levels influence mammographic density and breast cancer risk. Therefore, we examined these associations in the Nurses' Health Study (NHS) and Nurses' Health Study II (NHSII), two large prospective cohorts with information on PMD and circulating lipid measures, long follow-up, and breast cancer risk factor and outcome data.
METHODS: We conducted a nested case-control study among women in the NHS and NHSII. Percent mammographic density (PMD) was measured using Cumulus software, a computer-assisted method, on digitized film mammograms. Cross-sectional associations between circulating lipids [total cholesterol (n = 1,502), high-density lipoprotein (HDL-C; n = 579), and triglycerides (n = 655)] and PMD were evaluated among controls. All analyses were stratified by menopausal status at time of mammogram. Relative risks for breast cancer by lipid and PMD measures were estimated among postmenopausal women in the full nested case-control study (cases/controls for cholesterol, HDL-C, and triglycerides were 937/975, 416/449, and 506/537, respectively).
RESULTS: There were no significant associations between circulating lipid levels and PMD among healthy women, irrespective of menopausal status. The association between PMD and breast cancer risk among postmenopausal women was not modified by circulating lipid levels (p interaction = 0.83, 0.80, and 0.34 for total cholesterol, HDL-C, and triglycerides, respectively).
CONCLUSION: Overall, no association was observed between lipid levels and PMD, and there was no evidence that lipid levels modified the association between PMD and breast cancer risk.

Entities:  

Keywords:  Breast density; Breast neoplasms; Cholesterol; Lipids; Mammography

Mesh:

Substances:

Year:  2019        PMID: 31264139      PMCID: PMC6778452          DOI: 10.1007/s10552-019-01201-2

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  38 in total

1.  Associations among circulating sex hormones, insulin-like growth factor, lipids, and mammographic density in postmenopausal women.

Authors:  Erin J Aiello; Shelley S Tworoger; Yutaka Yasui; Frank Z Stanczyk; John Potter; Cornelia M Ulrich; Melinda Irwin; Anne McTiernan
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2005-06       Impact factor: 4.254

2.  The interaction between metabolism, cancer and cardiovascular disease, connected by 27-hydroxycholesterol.

Authors:  Wan-Ru Lee; Tomonori Ishikawa; Michihisa Umetani
Journal:  Clin Lipidol       Date:  2014

3.  Premenopausal plasma ferritin levels, HFE polymorphisms, and risk of breast cancer in the nurses' health study II.

Authors:  Rebecca E Graff; Eunyoung Cho; Sara Lindström; Peter Kraft; Walter C Willett; A Heather Eliassen
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-01-17       Impact factor: 4.254

4.  Premenopausal insulin-like growth factor-I serum levels and changes in breast density over menopause.

Authors:  Martijn Verheus; Petra H M Peeters; Rudolf Kaaks; Paulus A H van Noord; Diederick E Grobbee; Carla H van Gils
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-03       Impact factor: 4.254

5.  High-density lipoprotein-cholesterol, daily estradiol and progesterone, and mammographic density phenotypes in premenopausal women.

Authors:  Vidar G Flote; Hanne Frydenberg; Giske Ursin; Anita Iversen; Morten W Fagerland; Peter T Ellison; Erik A Wist; Thore Egeland; Tom Wilsgaard; Anne McTiernan; Anne-Sofie Furberg; Inger Thune
Journal:  Cancer Prev Res (Phila)       Date:  2015-03-24

6.  Serum lipids and breast cancer risk: a cohort study of 5,207 Danish women.

Authors:  A P Høyer; G Engholm
Journal:  Cancer Causes Control       Date:  1992-09       Impact factor: 2.506

7.  Determination of blood pressure percentiles in normal-weight children: some methodological issues.

Authors:  B Rosner; N Cook; R Portman; S Daniels; B Falkner
Journal:  Am J Epidemiol       Date:  2008-01-29       Impact factor: 4.897

8.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

9.  Endogenous hormone levels, mammographic density, and subsequent risk of breast cancer in postmenopausal women.

Authors:  Rulla M Tamimi; Celia Byrne; Graham A Colditz; Susan E Hankinson
Journal:  J Natl Cancer Inst       Date:  2007-07-24       Impact factor: 13.506

Review 10.  Mammographic density. Potential mechanisms of breast cancer risk associated with mammographic density: hypotheses based on epidemiological evidence.

Authors:  Lisa J Martin; Norman F Boyd
Journal:  Breast Cancer Res       Date:  2008-01-09       Impact factor: 6.466

View more
  2 in total

1.  Alcohol and Tobacco Use in Relation to Mammographic Density in 23,456 Women.

Authors:  Laurel A Habel; Weiva Sieh; Russell B McBride; Kezhen Fei; Joseph H Rothstein; Stacey E Alexeeff; Xiaoyu Song; Lori C Sakoda; Valerie McGuire; Ninah Achacoso; Luana Acton; Rhea Y Liang; Jafi A Lipson; Martin J Yaffe; Daniel L Rubin; Alice S Whittemore
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2020-02-17       Impact factor: 4.254

2.  A Metabolomics Analysis of Circulating Carotenoids and Breast Cancer Risk.

Authors:  Rulla M Tamimi; A Heather Eliassen; Cheng Peng; Oana A Zeleznik; Katherine H Shutta; Bernard A Rosner; Peter Kraft; Clary B Clish; Meir J Stampfer; Walter C Willett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-10-25       Impact factor: 4.090

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.